2-N-cyclohexyl-4-N-(2-methyl-1H-inden-5-yl)pyrimidine-2,4-diamine;N-[2-(cyclopropylmethyl)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;N-[5-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)methyl]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;N-[2-(4-fluorophenoxy)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;2-N-(2-methoxy-4-pyridinyl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;2-N-(2-methoxypyrimidin-4-yl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;N-[5-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;2-methyl-N-[2-(4-phenoxyphenoxy)pyrimidin-4-yl]-1H-indol-5-amine

C159H151F2N39O10S2 — CID 158235407

IUPAC2-N-cyclohexyl-4-N-(2-methyl-1H-inden-5-yl)pyrimidine-2,4-diamine;N-[2-(cyclopropylmethyl)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;N-[5-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)methyl]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;N-[2-(4-fluorophenoxy)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;2-N-(2-methoxy-4-pyridinyl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;2-N-(2-methoxypyrimidin-4-yl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;N-[5-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;2-methyl-N-[2-(4-phenoxyphenoxy)pyrimidin-4-yl]-1H-indol-5-amine
SMILESCC1=Cc2cc(Nc3ccnc(NC4CCCCC4)n3)ccc2C1.COc1cc(Nc2nccc(Nc3ccc4[nH]c(C)cc4c3)n2)ccn1.COc1nccc(Nc2nccc(Nc3ccc4[nH]c(C)cc4c3)n2)n1.Cc1cc2c(F)c(Cc3ccnc(Cc4ccc(NS(C)(=O)=O)nc4)n3)ccc2[nH]1.Cc1cc2cc(Nc3ccnc(CC4CC4)n3)ccc2[nH]1.Cc1cc2cc(Nc3ccnc(Oc4ccc(F)cc4)n3)ccc2[nH]1.Cc1cc2cc(Nc3ccnc(Oc4ccc(Oc5ccccc5)cc4)n3)ccc2[nH]1.Cc1cc2cc(Oc3ccnc(Cc4ccc(NS(C)(=O)=O)nc4)n3)ccc2[nH]1
InChIInChI=1S/C25H20N4O2.C21H20FN5O2S.C20H19N5O3S.C20H24N4.C19H15FN4O.C19H18N6O.C18H17N7O.C17H18N4/c1-17-15-18-16-19(7-12-23(18)27-17)28-24-13-14-26-25(29-24)31-22-10-8-21(9-11-22)30-20-5-3-2-4-6-20;1-13-9-17-18(25-13)5-4-15(21(17)22)11-16-7-8-23-20(26-16)10-14-3-6-19(24-12-14)27-30(2,28)29;1-13-9-15-11-16(4-5-17(15)23-13)28-20-7-8-21-19(24-20)10-14-3-6-18(22-12-14)25-29(2,26)27;1-14-11-15-7-8-18(13-16(15)12-14)22-19-9-10-21-20(24-19)23-17-5-3-2-4-6-17;1-12-10-13-11-15(4-7-17(13)22-12)23-18-8-9-21-19(24-18)25-16-5-2-14(20)3-6-16;1-12-9-13-10-14(3-4-16(13)22-12)23-17-6-8-21-19(25-17)24-15-5-7-20-18(11-15)26-2;1-11-9-12-10-13(3-4-14(12)21-11)22-15-5-7-19-17(23-15)24-16-6-8-20-18(25-16)26-2;1-11-8-13-10-14(4-5-15(13)19-11)20-16-6-7-18-17(21-16)9-12-2-3-12/h2-16,27H,1H3,(H,26,28,29);3-9,12,25H,10-11H2,1-2H3,(H,24,27);3-9,11-12,23H,10H2,1-2H3,(H,22,25);7-10,12-13,17H,2-6,11H2,1H3,(H2,21,22,23,24);2-11,22H,1H3,(H,21,23,24);3-11,22H,1-2H3,(H2,20,21,23,24,25);3-10,21H,1-2H3,(H2,19,20,22,23,24,25);4-8,10,12,19H,2-3,9H2,1H3,(H,18,20,21)
InChIKeyGEXABTGBVGUQFA-UHFFFAOYSA-N
MW2870.35 g/mol
LogP34.90
Rot. Bonds40

About 2-N-cyclohexyl-4-N-(2-methyl-1H-inden-5-yl)pyrimidine-2,4-diamine;N-[2-(cyclopropylmethyl)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;N-[5-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)methyl]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;N-[2-(4-fluorophenoxy)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;2-N-(2-methoxy-4-pyridinyl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;2-N-(2-methoxypyrimidin-4-yl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;N-[5-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;2-methyl-N-[2-(4-phenoxyphenoxy)pyrimidin-4-yl]-1H-indol-5-amine

2-N-cyclohexyl-4-N-(2-methyl-1H-inden-5-yl)pyrimidine-2,4-diamine;N-[2-(cyclopropylmethyl)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;N-[5-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)methyl]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;N-[2-(4-fluorophenoxy)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;2-N-(2-methoxy-4-pyridinyl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;2-N-(2-methoxypyrimidin-4-yl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;N-[5-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;2-methyl-N-[2-(4-phenoxyphenoxy)pyrimidin-4-yl]-1H-indol-5-amine (PubChem CID 158235407) has the molecular formula C159H151F2N39O10S2 and a molecular weight of 2870.35 g/mol. Its IUPAC name is 2-N-cyclohexyl-4-N-(2-methyl-1H-inden-5-yl)pyrimidine-2,4-diamine;N-[2-(cyclopropylmethyl)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;N-[5-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)methyl]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;N-[2-(4-fluorophenoxy)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;2-N-(2-methoxy-4-pyridinyl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;2-N-(2-methoxypyrimidin-4-yl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;N-[5-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;2-methyl-N-[2-(4-phenoxyphenoxy)pyrimidin-4-yl]-1H-indol-5-amine.

Molecular Properties

Compound Name2-N-cyclohexyl-4-N-(2-methyl-1H-inden-5-yl)pyrimidine-2,4-diamine;N-[2-(cyclopropylmethyl)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;N-[5-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)methyl]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;N-[2-(4-fluorophenoxy)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;2-N-(2-methoxy-4-pyridinyl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;2-N-(2-methoxypyrimidin-4-yl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;N-[5-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;2-methyl-N-[2-(4-phenoxyphenoxy)pyrimidin-4-yl]-1H-indol-5-amine
PubChem CID158235407
Molecular FormulaC159H151F2N39O10S2
Molecular Weight2870.35 g/mol
Exact Mass2868.19
IUPAC Name2-N-cyclohexyl-4-N-(2-methyl-1H-inden-5-yl)pyrimidine-2,4-diamine;N-[2-(cyclopropylmethyl)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;N-[5-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)methyl]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;N-[2-(4-fluorophenoxy)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;2-N-(2-methoxy-4-pyridinyl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;2-N-(2-methoxypyrimidin-4-yl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;N-[5-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;2-methyl-N-[2-(4-phenoxyphenoxy)pyrimidin-4-yl]-1H-indol-5-amine
SMILESCC1=Cc2cc(Nc3ccnc(NC4CCCCC4)n3)ccc2C1.COc1cc(Nc2nccc(Nc3ccc4[nH]c(C)cc4c3)n2)ccn1.COc1nccc(Nc2nccc(Nc3ccc4[nH]c(C)cc4c3)n2)n1.Cc1cc2c(F)c(Cc3ccnc(Cc4ccc(NS(C)(=O)=O)nc4)n3)ccc2[nH]1.Cc1cc2cc(Nc3ccnc(CC4CC4)n3)ccc2[nH]1.Cc1cc2cc(Nc3ccnc(Oc4ccc(F)cc4)n3)ccc2[nH]1.Cc1cc2cc(Nc3ccnc(Oc4ccc(Oc5ccccc5)cc4)n3)ccc2[nH]1.Cc1cc2cc(Oc3ccnc(Cc4ccc(NS(C)(=O)=O)nc4)n3)ccc2[nH]1
InChIInChI=1S/C25H20N4O2.C21H20FN5O2S.C20H19N5O3S.C20H24N4.C19H15FN4O.C19H18N6O.C18H17N7O.C17H18N4/c1-17-15-18-16-19(7-12-23(18)27-17)28-24-13-14-26-25(29-24)31-22-10-8-21(9-11-22)30-20-5-3-2-4-6-20;1-13-9-17-18(25-13)5-4-15(21(17)22)11-16-7-8-23-20(26-16)10-14-3-6-19(24-12-14)27-30(2,28)29;1-13-9-15-11-16(4-5-17(15)23-13)28-20-7-8-21-19(24-20)10-14-3-6-18(22-12-14)25-29(2,26)27;1-14-11-15-7-8-18(13-16(15)12-14)22-19-9-10-21-20(24-19)23-17-5-3-2-4-6-17;1-12-10-13-11-15(4-7-17(13)22-12)23-18-8-9-21-19(24-18)25-16-5-2-14(20)3-6-16;1-12-9-13-10-14(3-4-16(13)22-12)23-17-6-8-21-19(25-17)24-15-5-7-20-18(11-15)26-2;1-11-9-12-10-13(3-4-14(12)21-11)22-15-5-7-19-17(23-15)24-16-6-8-20-18(25-16)26-2;1-11-8-13-10-14(4-5-15(13)19-11)20-16-6-7-18-17(21-16)9-12-2-3-12/h2-16,27H,1H3,(H,26,28,29);3-9,12,25H,10-11H2,1-2H3,(H,24,27);3-9,11-12,23H,10H2,1-2H3,(H,22,25);7-10,12-13,17H,2-6,11H2,1H3,(H2,21,22,23,24);2-11,22H,1H3,(H,21,23,24);3-11,22H,1-2H3,(H2,20,21,23,24,25);3-10,21H,1-2H3,(H2,19,20,22,23,24,25);4-8,10,12,19H,2-3,9H2,1H3,(H,18,20,21)
InChIKeyGEXABTGBVGUQFA-UHFFFAOYSA-N
XLogP34.90
TPSA637.21 Ų
H-Bond Donors18
H-Bond Acceptors40
Rotatable Bonds40
Heavy Atoms212
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002870.35
LogP ≤ 534.90
H-Bond Donors ≤ 518
H-Bond Acceptors ≤ 1040

Analyze 2-N-cyclohexyl-4-N-(2-methyl-1H-inden-5-yl)pyrimidine-2,4-diamine;N-[2-(cyclopropylmethyl)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;N-[5-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)methyl]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;N-[2-(4-fluorophenoxy)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;2-N-(2-methoxy-4-pyridinyl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;2-N-(2-methoxypyrimidin-4-yl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;N-[5-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;2-methyl-N-[2-(4-phenoxyphenoxy)pyrimidin-4-yl]-1H-indol-5-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-N-cyclohexyl-4-N-(2-methyl-1H-inden-5-yl)pyrimidine-2,4-diamine;N-[2-(cyclopropylmethyl)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;N-[5-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)methyl]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;N-[2-(4-fluorophenoxy)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;2-N-(2-methoxy-4-pyridinyl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;2-N-(2-methoxypyrimidin-4-yl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;N-[5-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;2-methyl-N-[2-(4-phenoxyphenoxy)pyrimidin-4-yl]-1H-indol-5-amine?
The IUPAC name of 2-N-cyclohexyl-4-N-(2-methyl-1H-inden-5-yl)pyrimidine-2,4-diamine;N-[2-(cyclopropylmethyl)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;N-[5-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)methyl]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;N-[2-(4-fluorophenoxy)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;2-N-(2-methoxy-4-pyridinyl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;2-N-(2-methoxypyrimidin-4-yl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;N-[5-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;2-methyl-N-[2-(4-phenoxyphenoxy)pyrimidin-4-yl]-1H-indol-5-amine (CID 158235407) is 2-N-cyclohexyl-4-N-(2-methyl-1H-inden-5-yl)pyrimidine-2,4-diamine;N-[2-(cyclopropylmethyl)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;N-[5-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)methyl]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;N-[2-(4-fluorophenoxy)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;2-N-(2-methoxy-4-pyridinyl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;2-N-(2-methoxypyrimidin-4-yl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;N-[5-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;2-methyl-N-[2-(4-phenoxyphenoxy)pyrimidin-4-yl]-1H-indol-5-amine.
What is the SMILES notation for 2-N-cyclohexyl-4-N-(2-methyl-1H-inden-5-yl)pyrimidine-2,4-diamine;N-[2-(cyclopropylmethyl)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;N-[5-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)methyl]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;N-[2-(4-fluorophenoxy)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;2-N-(2-methoxy-4-pyridinyl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;2-N-(2-methoxypyrimidin-4-yl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;N-[5-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;2-methyl-N-[2-(4-phenoxyphenoxy)pyrimidin-4-yl]-1H-indol-5-amine?
The canonical SMILES for 2-N-cyclohexyl-4-N-(2-methyl-1H-inden-5-yl)pyrimidine-2,4-diamine;N-[2-(cyclopropylmethyl)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;N-[5-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)methyl]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;N-[2-(4-fluorophenoxy)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;2-N-(2-methoxy-4-pyridinyl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;2-N-(2-methoxypyrimidin-4-yl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;N-[5-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;2-methyl-N-[2-(4-phenoxyphenoxy)pyrimidin-4-yl]-1H-indol-5-amine is CC1=Cc2cc(Nc3ccnc(NC4CCCCC4)n3)ccc2C1.COc1cc(Nc2nccc(Nc3ccc4[nH]c(C)cc4c3)n2)ccn1.COc1nccc(Nc2nccc(Nc3ccc4[nH]c(C)cc4c3)n2)n1.Cc1cc2c(F)c(Cc3ccnc(Cc4ccc(NS(C)(=O)=O)nc4)n3)ccc2[nH]1.Cc1cc2cc(Nc3ccnc(CC4CC4)n3)ccc2[nH]1.Cc1cc2cc(Nc3ccnc(Oc4ccc(F)cc4)n3)ccc2[nH]1.Cc1cc2cc(Nc3ccnc(Oc4ccc(Oc5ccccc5)cc4)n3)ccc2[nH]1.Cc1cc2cc(Oc3ccnc(Cc4ccc(NS(C)(=O)=O)nc4)n3)ccc2[nH]1.
What is the InChIKey of 2-N-cyclohexyl-4-N-(2-methyl-1H-inden-5-yl)pyrimidine-2,4-diamine;N-[2-(cyclopropylmethyl)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;N-[5-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)methyl]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;N-[2-(4-fluorophenoxy)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;2-N-(2-methoxy-4-pyridinyl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;2-N-(2-methoxypyrimidin-4-yl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;N-[5-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;2-methyl-N-[2-(4-phenoxyphenoxy)pyrimidin-4-yl]-1H-indol-5-amine?
The InChIKey is GEXABTGBVGUQFA-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H20N4O2.C21H20FN5O2S.C20H19N5O3S.C20H24N4.C19H15FN4O.C19H18N6O.C18H17N7O.C17H18N4/c1-17-15-18-16-19(7-12-23(18)27-17)28-24-13-14-26-25(29-24)31-22-10-8-21(9-11-22)30-20-5-3-2-4-6-20;1-13-9-17-18(25-13)5-4-15(21(17)22)11-16-7-8-23-20(26-16)10-14-3-6-19(24-12-14)27-30(2,28)29;1-13-9-15-11-16(4-5-17(15)23-13)28-20-7-8-21-19(24-20)10-14-3-6-18(22-12-14)25-29(2,26)27;1-14-11-15-7-8-18(13-16(15)12-14)22-19-9-10-21-20(24-19)23-17-5-3-2-4-6-17;1-12-10-13-11-15(4-7-17(13)22-12)23-18-8-9-21-19(24-18)25-16-5-2-14(20)3-6-16;1-12-9-13-10-14(3-4-16(13)22-12)23-17-6-8-21-19(25-17)24-15-5-7-20-18(11-15)26-2;1-11-9-12-10-13(3-4-14(12)21-11)22-15-5-7-19-17(23-15)24-16-6-8-20-18(25-16)26-2;1-11-8-13-10-14(4-5-15(13)19-11)20-16-6-7-18-17(21-16)9-12-2-3-12/h2-16,27H,1H3,(H,26,28,29);3-9,12,25H,10-11H2,1-2H3,(H,24,27);3-9,11-12,23H,10H2,1-2H3,(H,22,25);7-10,12-13,17H,2-6,11H2,1H3,(H2,21,22,23,24);2-11,22H,1H3,(H,21,23,24);3-11,22H,1-2H3,(H2,20,21,23,24,25);3-10,21H,1-2H3,(H2,19,20,22,23,24,25);4-8,10,12,19H,2-3,9H2,1H3,(H,18,20,21).
What are the key properties of 2-N-cyclohexyl-4-N-(2-methyl-1H-inden-5-yl)pyrimidine-2,4-diamine;N-[2-(cyclopropylmethyl)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;N-[5-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)methyl]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;N-[2-(4-fluorophenoxy)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;2-N-(2-methoxy-4-pyridinyl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;2-N-(2-methoxypyrimidin-4-yl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;N-[5-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;2-methyl-N-[2-(4-phenoxyphenoxy)pyrimidin-4-yl]-1H-indol-5-amine?
2-N-cyclohexyl-4-N-(2-methyl-1H-inden-5-yl)pyrimidine-2,4-diamine;N-[2-(cyclopropylmethyl)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;N-[5-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)methyl]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;N-[2-(4-fluorophenoxy)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;2-N-(2-methoxy-4-pyridinyl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;2-N-(2-methoxypyrimidin-4-yl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;N-[5-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;2-methyl-N-[2-(4-phenoxyphenoxy)pyrimidin-4-yl]-1H-indol-5-amine has a molecular weight of 2870.35 g/mol, XLogP of 34.90, 40 rotatable bonds, 18 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for 2-N-cyclohexyl-4-N-(2-methyl-1H-inden-5-yl)pyrimidine-2,4-diamine;N-[2-(cyclopropylmethyl)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;N-[5-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)methyl]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;N-[2-(4-fluorophenoxy)pyrimidin-4-yl]-2-methyl-1H-indol-5-amine;2-N-(2-methoxy-4-pyridinyl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;2-N-(2-methoxypyrimidin-4-yl)-4-N-(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine;N-[5-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]methyl]-2-pyridinyl]methanesulfonamide;2-methyl-N-[2-(4-phenoxyphenoxy)pyrimidin-4-yl]-1H-indol-5-amine is sourced from PubChem (CID 158235407), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).